In the last 12 months, insiders at Glucotrack, Inc. ($GCTK) filed 77 transactions with the SEC: 13 open-market purchases totaling $490,000 and 0 sales totaling $0. Net insider sentiment: net buying.
Glucotrack, Inc. operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- John A. Ballantyne Revocable Living Trust dated 08/01/2017 (TenPercentOwner) — 8 transactions totaling $4,093,116
- BALLANTYNE JOHN (Director) — 9 transactions totaling $4,093,116
- Malave Luis (Director) — 21 transactions totaling $629,674
- SYCOFF DREW (Director) — 2 transactions totaling $230,000
- Carter Erin Catherine (Director) — 14 transactions totaling $179,665
View all SEC Filings for Glucotrack, Inc. (GCTK).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2025 | Goode Paul | Chief Executive Officer | J | Common Stock, par value $0.001 per share | 42 | $0.00 | 339.0000 | 0 | 14.14% | 0.00% |
| Oct. 3, 2025 | Carter Erin Catherine | Director | A | Stock option (right to buy) | 4055 | $0.00 | 4,055.0000 | 25,585,853 | 9999.99% | 0.02% |
| Oct. 3, 2025 | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 386 | $0.00 | 2,148.0000 | 25,585,853 | 21.91% | 0.00% |
| July 11, 2025 | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 1000 | $0.00 | 1,762.0000 | 25,585,853 | 131.23% | 0.00% |
| March 25, 2025 | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 32 | $0.00 | 762.0000 | 0 | 4.38% | 0.00% |
| Oct. 3, 2025 | Malave Luis | Director | A | Stock option (right to buy) | 4055 | $0.00 | 4,055.0000 | 25,585,853 | 9999.99% | 0.02% |
| Oct. 3, 2025 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 463 | $0.00 | 4,058.0000 | 25,585,853 | 12.88% | 0.00% |
| July 11, 2025 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 1200 | $0.00 | 3,595.0000 | 25,585,853 | 50.10% | 0.00% |
| March 25, 2025 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 35 | $0.00 | 2,395.0000 | 0 | 1.48% | 0.00% |
| Oct. 3, 2025 | Balo Andrew K | Director | A | Stock option (right to buy) | 4055 | $0.00 | 4,055.0000 | 25,585,853 | 9999.99% | 0.02% |
| Oct. 3, 2025 | Balo Andrew K | Director | A | Common Stock, par value $0.001 per share | 1285 | $0.00 | 4,692.0000 | 25,585,853 | 37.72% | 0.01% |
| July 11, 2025 | Balo Andrew K | Director | A | Common Stock, par value $0.001 per share | 3332 | $0.00 | 3,407.0000 | 25,585,853 | 4442.67% | 0.01% |
| March 25, 2025 | Balo Andrew K | Director | A | Common Stock, par value $0.001 per share | 75 | $0.00 | 75.0000 | 0 | 9999.99% | 0.00% |
| July 30, 2024 | BALLANTYNE JOHN | Director | P | Warrants to Purchase Common Stock | 59260 | $0.00 | 59,260.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | BALLANTYNE JOHN | Director | A | Series A Common Warrant | 132036 | $0.00 | 132,036.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | BALLANTYNE JOHN | Director | A | Series B Common Warrant | 132036 | $0.00 | 132,036.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2025 | BALLANTYNE JOHN | Director | X | Series B Common Warrant | 132036 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 30, 2021 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 8 | $0.00 | 8.0000 | 0 | 9999.99% | 0.00% |
| Dec. 31, 2021 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 11 | $0.00 | 19.0000 | 0 | 137.50% | 0.00% |
| March 31, 2022 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 25 | $0.00 | 44.0000 | 0 | 131.58% | 0.00% |
| June 30, 2022 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 34 | $0.00 | 78.0000 | 0 | 77.27% | 0.00% |
| Oct. 4, 2022 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 44 | $0.00 | 122.0000 | 0 | 56.41% | 0.00% |
| Jan. 9, 2023 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 29 | $0.00 | 151.0000 | 0 | 23.77% | 0.00% |
| April 20, 2023 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 121 | $0.00 | 272.0000 | 0 | 80.13% | 0.00% |
| Dec. 31, 2023 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 362 | $0.00 | 634.0000 | 0 | 133.09% | 0.00% |
| April 8, 2024 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 489 | $0.00 | 1,123.0000 | 0 | 77.13% | 0.00% |
| Nov. 14, 2024 | Malave Luis | Director | C | Common Stock, par value $0.001 per share | 6886 | $31.20 | 8,009.0000 | 0 | 613.18% | 0.00% |
| March 12, 2025 | Malave Luis | Director | X | Common Stock, par value $0.001 per share | 133532 | $0.00 | 141,541.0000 | 0 | 1667.27% | 0.00% |
| March 26, 2025 | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 2076 | $0.00 | 143,617.0000 | 0 | 1.47% | 0.00% |
| Nov. 14, 2024 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 | TenPercentOwner | J | Common Stock, par value $0.001 per share | 132036 | $31.00 | 183,039.0000 | 0 | 258.88% | 0.00% |
| Nov. 14, 2024 | Malave Luis | Director | C | Convertible Promissory Note | 214831 | $214831.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 14, 2024 | Malave Luis | Director | A | Series A Common Warrant | 6886 | $0.00 | 6,886.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Malave Luis | Director | A | Series B Common Warrant | 6886 | $0.00 | 6,886.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2025 | Malave Luis | Director | X | Series B Common Warrant | 6886 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 31, 2023 | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 903 | $0.00 | 903.0000 | 0 | 9999.99% | 0.00% |
| April 8, 2024 | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 458 | $0.00 | 1,361.0000 | 0 | 50.72% | 0.00% |
| Nov. 14, 2024 | Carter Erin Catherine | Director | C | Common Stock, par value $0.001 per share | 2078 | $31.20 | 3,439.0000 | 0 | 152.68% | 0.00% |
| March 12, 2025 | Carter Erin Catherine | Director | X | Common Stock, par value $0.001 per share | 40297 | $0.00 | 43,736.0000 | 0 | 1171.77% | 0.00% |
| March 26, 2025 | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 1896 | $0.00 | 45,632.0000 | 0 | 4.34% | 0.00% |
| July 18, 2024 | Carter Erin Catherine | Director | P | Convertible Promissory Note | 50000 | $50000.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Carter Erin Catherine | Director | C | Convertible Promissory Note | 64831 | $64831.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Nov. 14, 2024 | Carter Erin Catherine | Director | A | Series A Common Warrant | 2078 | $0.00 | 2,078.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Carter Erin Catherine | Director | A | Series B Common Warrant | 2078 | $0.00 | 2,078.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2025 | Carter Erin Catherine | Director | X | Series B Common Warrant | 2078 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 18, 2024 | Malave Luis | Director | P | Convertible Promissory Note | 200000 | $200000.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2025 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 | TenPercentOwner | X | Common Stock, par value $0.001 per share | 2560553 | $0.00 | 2,743,591.0000 | 0 | 1398.92% | 0.00% |
| July 30, 2024 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 | TenPercentOwner | P | Warrants to Purchase Common Stock | 106667 | $0.00 | 106,667.0000 | 0 | 9999.99% | 0.00% |
| July 30, 2024 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 | TenPercentOwner | P | Warrants to Purchase Common Stock | 76191 | $0.00 | 76,191.0000 | 0 | 9999.99% | 0.00% |
| July 30, 2024 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 | TenPercentOwner | P | Warrants to Purchase Common Stock | 59260 | $0.00 | 59,260.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 | TenPercentOwner | A | Series A Common Warrant | 132036 | $0.00 | 132,036.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 | TenPercentOwner | A | Series B Common Warrant | 132036 | $0.00 | 132,036.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2025 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 | TenPercentOwner | X | Series B Common Warrant | 132036 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 14, 2024 | BALLANTYNE JOHN | Director | J | Common Stock, par value $0.001 per share | 132036 | $31.00 | 187,165.0000 | 0 | 239.50% | 0.00% |
| March 12, 2025 | BALLANTYNE JOHN | Director | X | Common Stock, par value $0.001 per share | 2560553 | $0.00 | 2,747,717.0000 | 0 | 1368.08% | 0.00% |
| March 26, 2025 | BALLANTYNE JOHN | Director | A | Common Stock, par value $0.001 per share | 4126 | $0.00 | 2,747,717.0000 | 0 | 0.15% | 0.00% |
| July 30, 2024 | BALLANTYNE JOHN | Director | P | Warrants to Purchase Common Stock | 106667 | $0.00 | 106,667.0000 | 0 | 9999.99% | 0.00% |
| July 30, 2024 | BALLANTYNE JOHN | Director | P | Warrants to Purchase Common Stock | 76191 | $0.00 | 76,191.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Goode Paul | Chief Executive Officer | C | Common Stock, par value $0.001 per share | 796 | $31.20 | 2,054.0000 | 0 | 63.28% | 0.00% |
| Aug. 24, 2021 | Fischell Robert | Director | A | Common Stock, par value $0.001 per share | 318 | $0.00 | 318.0000 | 0 | 9999.99% | 0.00% |
| April 8, 2024 | Fischell Robert | Director | A | Common Stock, par value $0.001 per share | 229 | $0.00 | 547.0000 | 0 | 72.01% | 0.00% |
| March 26, 2025 | Fischell Robert | Director | A | Common Stock, par value $0.001 per share | 1498 | $0.00 | 2,045.0000 | 0 | 273.86% | 0.00% |
| March 12, 2025 | Goode Paul | Chief Executive Officer | X | Common Stock, par value $0.001 per share | 15435 | $0.00 | 18,989.0000 | 0 | 434.30% | 0.00% |
| Feb. 5, 2025 | Goode Paul | Chief Executive Officer | J | Common Stock, par value $0.001 per share | 1500 | $0.00 | 3,554.0000 | 0 | 73.03% | 0.00% |
| March 26, 2025 | Balo Andrew K | Director | A | Common Stock, par value $0.001 per share | 4490 | $0.00 | 4,490.0000 | 0 | 9999.99% | 0.00% |
| March 26, 2025 | Danzig Allen | Director | A | Common Stock, par value $0.001 per share | 1498 | $0.00 | 1,922.0000 | 0 | 353.30% | 0.00% |
| April 8, 2024 | Danzig Allen | Director | A | Common Stock, par value $0.001 per share | 229 | $0.00 | 424.0000 | 0 | 117.44% | 0.00% |
| Oct. 4, 2022 | Danzig Allen | Director | A | Common Stock, par value $0.001 per share | 44 | $0.00 | 195.0000 | 0 | 29.14% | 0.00% |
| March 12, 2025 | Goode Paul | Chief Executive Officer | X | Series B Common Warrant | 796 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Nov. 14, 2024 | Goode Paul | Chief Executive Officer | A | Series B Common Warrant | 796 | $0.00 | 796.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Goode Paul | Chief Executive Officer | A | Series A Common Warrant | 796 | $0.00 | 796.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Goode Paul | Chief Executive Officer | C | Convertible Promissory Note | 24831 | $24831.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 18, 2024 | Goode Paul | Chief Executive Officer | P | Convertible Promissory Note | 10000 | $10000.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2024 | Goode Paul | Chief Executive Officer | P | Warrants to Purchase Common Stock | 2100 | $0.00 | 2,100.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Goode Paul | Chief Executive Officer | A | Stock option (right to buy) | 3277 | $0.00 | 3,277.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2024 | SYCOFF DREW | Director | P | Warrants to Purchase Common Stock | 138000 | $0.00 | 138,000.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2024 | Goode Paul | Chief Executive Officer | P | Warrants to Purchase Common Stock | 42000 | $0.00 | 42,000.0000 | 0 | 9999.99% | 0.00% |
| April 22, 2024 | SYCOFF DREW | Director | P | Common Stock | 182540 | $1.26 | 2,951,257.6000 | 0 | 6.59% | 0.00% |